January 28, 2015
Astellas Pharma will transfer its marketing authorization for three active pharmaceutical ingredients (APIs), mecasermin, dantrolene, and dimemorfan, to OrphanPacific, the two companies said on January 27. Under a deal signed on the same day, Astellas will transfer the three APIs...read more